Teva Pharmaceutical Industries (TEVA)

40.22 +0.03  +0.06%  May 21, 5:00PM
Add to Watchlists Create an Alert

Teva Pharmaceutical Industries Cash from Investing Quarterly:

-266.00M for March 31, 2013
View Full Chart

Teva Pharmaceutical Industries Cash from Investing Quarterly Chart

    Teva Pharmaceutical Industries Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -266.00M
    Dec. 31, 2012 -409.00M
    Sept. 30, 2012 -249.00M
    June 30, 2012 -282.00M
    March 31, 2012 -194.00M
    Dec. 31, 2011 -5.491B
    Sept. 30, 2011 -1.194B
    June 30, 2011 -240.00M
    March 31, 2011 -676.00M
    Dec. 31, 2010 -216.00M
    Sept. 30, 2010 -5.10B
    June 30, 2010 189.00M
    March 31, 2010 -328.00M
    Dec. 31, 2009 -263.00M
    Sept. 30, 2009 -336.00M
    June 30, 2009 -175.00M
    March 31, 2009 -142.00M
    Dec. 31, 2008 -3.856B
    Sept. 30, 2008 -154.00M
    June 30, 2008 -242.00M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    TEVA Cash from Investing Quarterly Benchmarks

    Companies
    Pfizer
    Mylan -142.26M
    Alexza Pharmaceuticals -0.438M

    TEVA Cash from Investing Quarterly Rankings

    Overall 47th percentile
    4184 of 8002
    Sector 21st percentile
    538 of 684 in Healthcare
    Industry 19th percentile
    55 of 68 in Drug Manufacturers - Specialty & Generic

    TEVA Cash from Investing Quarterly Range, Past 5 Years

    Minimum -5.491B Dec 2011
    Maximum 189.00M Jun 2010
    Average -981.20M